PURCHASE, NY, March 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to 21 new employees.
Effective February 28, 2025 and March 1, 2025, in connection with the acquisition of Catapult Health on February 28, 2025, 19 employees of Catapult Health were granted awards of restricted stock units covering an aggregate of 365,282 shares of Teladoc Health's common stock, par value $0.001 per share ("Common Stock"), and awards of performance stock units covering a target of 324,270 shares of Common Stock. The restricted stock units vest, based on continued service to Teladoc Health, over two or three years. The performance stock units provide a target number of shares of Common Stock that would be earned over two years based on various financial and operational metrics of Catapult Health and Teladoc Health.
Also, effective March 1, 2025, in connection with commencing employment, two additional new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 155,523 shares of Common Stock and awards of performance stock units covering a target of 125,523 shares of Common Stock (for which up to 251,046 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The performance stock units provide a target number of shares of Common Stock that would be earned over three years based on various financial metrics.
The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person's health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
